Skip to content
PICO Portalanswers from OpenAlex

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro

PaperCitations, authors & open-access status

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro is a paper indexed in PICO Portal from OpenAlex.

How many citations does Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro have?

PICO Portalcitation count

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro has 149 citations in the OpenAlex counts PICO Portal stores.

When was Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro published?

PICO Portalyear

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro has 2011 year in the PICO Portal index.

What is the open-access status of Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro?

PICO Portaloa status

Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro has closed oa status in the PICO Portal index.

What is the DOI of Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro?

PICO Portaldoi

The DOI for Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro is on the source record.

What is the PMID of Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro?

PICO Portalpmid

The PMID for Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro is on the source record.

What is the OpenAlex record for Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro?

PICO Portalopenalex

The OpenAlex for Kaempferol protects against doxorubicin-induced cardiotoxicity in vivo and in vitro is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial